pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 3
patritumab deruxtecan
patritumab deruxtecan
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Daiichi Sankyo Co Ltd
Phase 3
paxalisib
paxalisib
Recurrent Glioblastoma Multiforme (GBM)
$KZIA
KAZIA THERAPEUTICS LTD
Marketed
pazopanib hydrochloride
Pazopanib Hydrochloride
Renal Cell Carcinoma
Novugen Pharma (Malaysia) Sdn Bhd
← prev
page 54 of 62
next →
Pain
89
Neurology
1
pre_registration
pegargiminase
pegargiminase
Malignant Pleural Mesothelioma
$PII
Polaris Inc.
Marketed
pegaspargase
Oncaspar (pegaspargase)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Servier Pharmaceuticals LLC
Preclinical
pegfilgrastim biosimilar
Fylnetra (pegfilgrastim-pbbk)
Unspecified Cancer
Meitheal Pharmaceuticals Inc
Phase 3
pelabresib
pelabresib
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
$NVS
NOVARTIS AG
Phase 2
pelareorep
Reolysin (pelareorep)
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$ONCY
ONCOLYTICS BIOTECH INC
Phase 2
pelcitoclax
pelcitoclax [INN]
Neuroendocrine Tumors
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
Phase 2
peltopepimut-s
peltopepimut-s
Cervical Cancer
ISA Pharmaceuticals BV
Phase 2
peluntamig
peluntamig
Neuroendocrine Carcinoma
Phanes Therapeutics Inc
Phase 1
pembrolizumab biosimilar
Melanoma
Formycon AG
Marketed
pemetrexed
Pemfexy (pemetrexed [INN])
Malignant Pleural Mesothelioma
Eagle Pharmaceuticals Inc
Marketed
pemetrexed tromethamine
Pemetrexed Ditromethamine (pemetrexed tromethamine)
Malignant Pleural Mesothelioma
Hospira Inc
Marketed
pemigatinib
Pemazyre (pemigatinib)
Metastatic Bile Duct Cancer
$INCY
INCYTE CORP
Marketed
penpulimab
Penpulimab-Kcqx (penpulimab)
Nasopharyngeal Cancer
Akeso Inc
Marketed
pertuzumab
Perjeta (pertuzumab)
Human Epidermal Growth Factor Receptor 2 Positive Breast…
Genentech Inc
Phase 3
petosemtamab
petosemtamab
Recurrent Head And Neck Squamous Cell Carcinoma
Merus NV
Phase 2
pexastimogene devacirepvec
pexastimogene devacirepvec
Metastatic Renal Cell Carcinoma
Sillajen Biotherapeutics
Marketed
pexidartinib hydrochloride
Turalio (pexidartinib hydrochloride)
Tenosynovial Giant Cell Tumor
Daiichi Sankyo Co Ltd
Marketed
phenoxybenzamine hydrochloride
Phenoxybenzamine Hydrochloride
Pheochromocytoma
Novitium Pharma LLC
Phase 1
pidnarulex
pidnarulex [INN]
Prostate Cancer
Senhwa Biosciences Inc
Phase 2
pifusertib
pifusertib [INN]
Solid Tumor
Taiho Pharmaceutical Co Ltd
pre_registration
pimicotinib hydrochloride
pimicotinib hydrochloride
Tenosynovial Giant Cell Tumor
Abbisko Therapeutics Co Ltd
Phase 1
pinometostat
pinometostat [INN]
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Ipsen SA
Preclinical
piperlongumine
piperlongumine
Recurrent Glioblastoma Multiforme (GBM)
TargTex SA
Marketed
pirtobrutinib
Jaypirca (pirtobrutinib)
Chronic Lymphocytic Leukemia (CLL)
Eli Lilly and Co
pre_registration
pivekimab sunirine
pivekimab sunirine
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
$ABBV
AbbVie Inc.
Phase 3
plinabulin
plinabulin
Febrile Neutropenia
$BYSI
BeyondSpring Inc.
Phase 2
plixorafenib
plixorafenib
Central Nervous System (CNS) Tumor
Fore Biotherapeutics Inc
